Asrar Malik
13Patents
2h-index
19Co-inventors
51Inventor score
Filing activity: Jun 25, 1998 → Aug 31, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6204054A | Transcytosis vehicles and enchancers for drug delivery | Human Necessities | 18 | Expired |
| US8067389B2 | Silencing of TGFβ type II receptor expression by siRNA | Chemistry; Metallurgy | 9 | Active |
| US8912139B2 | Peptide compositions and methods for treating lung injury, asthma, anaphylaxis, angioedema, systemic vascular permeability syndromes, and nasal congestion | Chemistry; Metallurgy | 2 | Active |
| US9561192B2 | Compositions and methods for diagnosing or treating neutrophil-mediated inflammatory disease | Physics | 1 | Active |
| US7825101B2 | Modulation of MLCK-L expression and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US9872839B2 | Compositions and methods for diagnosing or treating neutrophil-mediated inflammatory disease | Physics | 0 | Active |
| US9248198B2 | Peptide compositions and methods for treating lung injury, asthma, anaphylaxis, angioedema, systemic vascular permeability syndromes, and nasal congestion | Chemistry; Metallurgy | 0 | Active |
| US10064911B2 | Peptides for treating cancer | Human Necessities | 0 | Active |
| US9675660B2 | Peptides for inhibiting angiogenesis | Human Necessities | 0 | Active |
| US7429563B2 | Peptide carrier for drug delivery | Human Necessities | 0 | Active |
| US11299524B2 | KIF13B-derived peptide and method of inhibiting angiogenesis | Chemistry; Metallurgy | 0 | Active |
| US8137968B2 | Selected endothelial progenitor cells and methods for use | Chemistry; Metallurgy | 0 | Active |
| US8168176B2 | CBLB for treating endotoxin-mediated disorders | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.